An Efficacy, Safety and Tolerability Study of Ixmyelocel-T Administered Via Transendocardial Catheter-based Injections to Subjects With Heart Failure Due to Ischemic Dilated Cardiomyopathy (IDCM) (ixCELL DCM)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01670981
Recruitment Status : Completed
First Posted : August 23, 2012
Last Update Posted : July 23, 2018
Information provided by (Responsible Party):
Vericel Corporation

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : March 7, 2018
  Actual Study Completion Date : March 7, 2018
  Certification/Extension First Submitted : November 3, 2016